Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Cardinal Health | 5.35% | $2.23M | $50.83B | 70.08% | 66 Neutral | |
| Waste Management | 5.06% | $2.10M | $99.26B | 8.91% | 76 Outperform | |
| Eli Lilly & Co | 5.05% | $2.10M | $927.57B | 7.72% | 72 Outperform | |
| McKesson | 4.99% | $2.08M | $114.08B | 45.14% | 62 Neutral | |
| Johnson & Johnson | 4.95% | $2.06M | $577.48B | 44.50% | 78 Outperform | |
| Northrop Grumman | 4.62% | $1.92M | $105.02B | 55.73% | 76 Outperform | |
| Chubb | 4.48% | $1.87M | $129.71B | 16.13% | 80 Outperform | |
| Casey's General | 4.37% | $1.82M | $24.87B | 69.72% | 68 Neutral | |
| Coca-Cola | 4.35% | $1.81M | $331.28B | 9.32% | 75 Outperform | |
| Rentokil Initial | 4.28% | $1.78M | $15.84B | 41.24% | 66 Neutral |